Open-label Study With Bosentan in Interstitial Lung Disease

Clinical trial NCT00319033 · COMPLETED

Trial details

NCT number: NCT00319033
Sponsor: Actelion
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Interstitial Lung Disease Scleroderma

Start date: 2004-07-01
Primary completion: 2006-02-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.